Tiziana CEO converts 1.05M stock units into shares

The RSUs vest in four installments on August 15 of 2025, 2026, 2027 and 2028.

Rhea-AI Filing Summary

Tiziana Life Sciences Ltd (TLSA) CEO Ivor Elrifi reported the exercise/conversion and disposition of 1,050,000 restricted stock units on August 15, 2026. The transactions also report acquisition of 1,050,000 common shares held indirectly through a trust. Each RSU is a contingent right to one common share; the units were granted on August 15, 2024. Reported post-transaction positions were 2,100,000 RSUs and 5,843,684 common shares held indirectly through a trust.

Insider Trade Summary

1,050,000 shares exercised/converted

Exercise 2 txns

Insider Elrifi Ivor

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit F1, F2	1,050,000	--	--
Exercise	COMMON STOCK F1	1,050,000	--	--

Holdings After Transaction: Restricted Stock Unit — 2,100,000 contracts (Direct); COMMON STOCK — 5,843,684 shares (Indirect, By trust)

Footnotes (2)

1. F1. Each restricted stock unit (RSU) represents a contingent right to receive one share of Issuer's common stock.
2. F2. The RSUs were granted on August 15, 2024 vesting in four installments on August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028.

Key Figures

Restricted stock units exercised/conversion and disposed: 1,050,000 RSUs Common shares acquired: 1,050,000 shares RSUs following transaction: 2,100,000 RSUs +1 more

4 metrics

Restricted stock units exercised/conversion and disposed 1,050,000 RSUs Transaction reported on August 15, 2026

Common shares acquired 1,050,000 shares Held indirectly through a trust; transaction reported on August 15, 2026

RSUs following transaction 2,100,000 RSUs Reported post-transaction position

Common shares following transaction 5,843,684 shares Reported post-transaction position; held indirectly through a trust

Key Terms

Restricted stock unit (RSU), contingent right, vesting in four installments

3 terms

Restricted stock unit (RSU) financial

"Each restricted stock unit (RSU) represents"

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

contingent right financial

"a contingent right to receive one share"

vesting in four installments financial

"vesting in four installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the TLSA CEO's RSU vesting schedule?

The RSUs vest in four installments on August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028. They were granted on August 15, 2024.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/29/2026 - 05:13 PM Accepted by SEC EDGAR 09/29/2026 - 05:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elrifi Ivor

(Last) (First) (Middle)

535 BOYLSTON STREET

(Street)

BOSTON MASSACHUSETTS 02116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Tiziana Life Sciences Ltd [ TLSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	08/15/2026		M		1,050,000	A	(1)	5,843,684	I	By trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	08/15/2026		M			1,050,000	(2)	(2)	COMMON STOCK	1,050,000	(1)	2,100,000	D

Explanation of Responses:

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of Issuer's common stock.

2. The RSUs were granted on August 15, 2024 vesting in four installments on August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028.

	/s/ Ivor Elrifi	09/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)